These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 9408026

  • 1. Trypsin- and SLIGRL-induced vascular relaxation and the inhibition by benzamidine derivatives.
    Glusa E, Saft A, Prasa D, Stürzebecher J.
    Thromb Haemost; 1997 Nov; 78(5):1399-403. PubMed ID: 9408026
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.
    Glusa E, Adam C.
    Br J Pharmacol; 2001 Jun; 133(3):422-8. PubMed ID: 11375259
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Proteinase-activated receptor-2 in rat aorta: structural requirements for agonist activity of receptor-activating peptides.
    Hollenberg MD, Saifeddine M, al-Ani B.
    Mol Pharmacol; 1996 Feb; 49(2):229-33. PubMed ID: 8632754
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of trypsin-induced endothelium-dependent vasorelaxation in the porcine coronary artery.
    Nakayama T, Hirano K, Nishimura J, Takahashi S, Kanaide H.
    Br J Pharmacol; 2001 Oct; 134(4):815-26. PubMed ID: 11606322
    [Abstract] [Full Text] [Related]

  • 9. Evidence for proteinase-activated receptor-2 (PAR-2)-mediated mitogenesis in coronary artery smooth muscle cells.
    Bretschneider E, Kaufmann R, Braun M, Wittpoth M, Glusa E, Nowak G, Schrör K.
    Br J Pharmacol; 1999 Apr; 126(8):1735-40. PubMed ID: 10372815
    [Abstract] [Full Text] [Related]

  • 10. Protease-activated receptor-2 turnover stimulated independently of receptor activation in porcine coronary endothelial cells.
    Hamilton JR, Chow JM, Cocks TM.
    Br J Pharmacol; 1999 Jun; 127(3):617-22. PubMed ID: 10401551
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PAR-2 elicits afferent arteriolar vasodilation by NO-dependent and NO-independent actions.
    Trottier G, Hollenberg M, Wang X, Gui Y, Loutzenhiser K, Loutzenhiser R.
    Am J Physiol Renal Physiol; 2002 May; 282(5):F891-7. PubMed ID: 11934700
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms underlying enhanced vasorelaxant response to protease-activated receptor 2-activating peptide in type 2 diabetic Goto-Kakizaki rat mesenteric artery.
    Matsumoto T, Ishida K, Taguchi K, Kobayashi T, Kamata K.
    Peptides; 2009 Sep; 30(9):1729-34. PubMed ID: 19540892
    [Abstract] [Full Text] [Related]

  • 18. Role of PGE(2) in protease-activated receptor-1, -2 and -4 mediated relaxation in the mouse isolated trachea.
    Lan RS, Knight DA, Stewart GA, Henry PJ.
    Br J Pharmacol; 2001 Jan; 132(1):93-100. PubMed ID: 11156565
    [Abstract] [Full Text] [Related]

  • 19. Endothelium-dependent contractile actions of proteinase-activated receptor-2-activating peptides in human umbilical vein: release of a contracting factor via a novel receptor.
    Saifeddine M, Roy SS, Al-Ani B, Triggle CR, Hollenberg MD.
    Br J Pharmacol; 1998 Dec; 125(7):1445-54. PubMed ID: 9884072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.